πŸ‡ΊπŸ‡Έ FDA
Patent

US 7666404

Glanders/meliodosis vaccines

granted A61KA61K2039/522A61K39/00

Quick answer

US patent 7666404 (Glanders/meliodosis vaccines) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/522, A61K39/00